ZYUS Life Sciences Corporation (ZYUS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.194x

Based on the latest financial reports, ZYUS Life Sciences Corporation (ZYUS) has a cash flow conversion efficiency ratio of 0.194x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.52 Million) by net assets (CA$-12.97 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ZYUS Life Sciences Corporation - Cash Flow Conversion Efficiency Trend (2022–2024)

This chart illustrates how ZYUS Life Sciences Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

ZYUS Life Sciences Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ZYUS Life Sciences Corporation ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beauty Community Public Company Limited BK:BEAUTY	0.033x
SHL Telemedicine Ltd American Depositary Shares NASDAQ:SHLT	-0.004x
Phenom Resources Corp V:PHNM	-0.007x
Jentayu Sustainables Bhd KLSE:5673	-0.071x
Aurora Mobile Ltd NASDAQ:JG	0.048x
Wellbiotec Co. Ltd. KO:010600	-0.033x
Singbao International Co Ltd TWO:6130	-0.015x
Wintec Co. Ltd KQ:320000	-0.043x

Annual Cash Flow Conversion Efficiency for ZYUS Life Sciences Corporation (2022–2024)

The table below shows the annual cash flow conversion efficiency of ZYUS Life Sciences Corporation from 2022 to 2024.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-5.34 Million	CA$-9.88 Million	1.848x	+338.00%
2023-12-31	CA$23.11 Million	CA$-17.95 Million	-0.776x	+61.55%
2022-12-31	CA$4.74 Million	CA$-9.57 Million	-2.019x	--

About ZYUS Life Sciences Corporation

V:ZYUS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$33.60 Million

CA$46.44 Million CAD

Market Cap Rank

#26005 Global

#795 in Canada

Share Price

CA$0.58

Change (1 day)

+0.00%

52-Week Range

CA$0.50 - CA$0.82

All Time High

CA$2.05